Pyxis Oncology Inc

PYXS NASDAQ Santé & Biotech États-Unis US7473241013
2.03 $
6.84 %

Pyxis Oncology est axée sur le développement de thérapies contre le cancer par des immunothérapies et d'autres approches biologiques innovantes.

Performance & Momentum

6 Months 59.22 %
1 Year 73.50 %
3 Years 30.00 %
5 Years 84.62 %

Similar stocks to Pyxis Oncology Inc

Anantys Community

Be the first to share your analysis on Pyxis Oncology Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases